Press Releases - 2022-01-05

Date	Title	Company
05-Jan-2022	BIOCAPTIVA Provides Update and Remains on Track to Transform the Liquid Biopsy Market for Cancer Management	BIOCAPTIVA
05-Jan-2022	Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca	Covis Pharma Group
05-Jan-2022	OXURION to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference	OXURION
05-Jan-2022	Genmab and Synaffix Enter into License Agreement for ADC Technology	Genmab
05-Jan-2022	Thrombolytic Science Granted a Second US Patent on Its Clot Dissolving Therapy, A Novel, Nature-inspired Treatment for Ischemic Strokes	Thrombolytic Science, LLC
05-Jan-2022	Hansa Biopharma enters into agreement with AskBio to evaluate feasibility of imlifidase as pre-treatment ahead of gene therapy in Pompe disease	Hansa Biopharma
05-Jan-2022	AlzeCure presents novel Alzstatin data at the 11th Pharmaceutical Profiling meeting	AlzeCure
05-Jan-2022	ProQR Announces Last Patient Has Completed 12 Month Visit in Phase 2/3 Illuminate Trial of Sepofarsen	ProQR Therapeutics N.V.
05-Jan-2022	ICR responds to NICE decision not to recommend olaparib for advanced prostate cancer	The Institute of Cancer Research
05-Jan-2022	Calibre Scientific Acquires AmpliTech, a French Distributor of Reagents and Instruments Specializing in Molecular Pathology, Cytogenetics, and Molecular Genetics	Calibre Scientific
05-Jan-2022	Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region	Santhera
05-Jan-2022	Novo Holdings participates in EUR 110 million first closing of Sound Bioventures Fund I	Novo Holdings
05-Jan-2022	NHS Wales and Roche Diagnostics embark on blockchain journey with Digipharm	Digipharm
05-Jan-2022	Information on the Total Number of Voting Rights (Denominator) following conversion notices from NEGMA	Oxurion NV
05-Jan-2022	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
05-Jan-2022	Iktos and Astrogen Announce a Research Collaboration to Use Artificial Intelligence Platform for Drug Design against a Novel Parkinson’s Disease Target	Businesswire
05-Jan-2022	BioSpace Announces Top New Biopharma Companies to Watch in 2022	Businesswire
05-Jan-2022	Thrombolytic Science Granted a Second US Patent on Its Clot Dissolving Therapy, A Novel, Nature-inspired Treatment for Ischemic Strokes	B3C newswire
05-Jan-2022	Growing Demand For New Treatment Options Is Likely To Propel The Growth Of The Athletic Knee Treatment	MARKITWIRED Latest Market Reports
05-Jan-2022	Ion Channel Modulators Market Expansion to be Persistent through 2021-2031; Development of New Screening Technologies to Augment Market Growth	MARKITWIRED Latest Market Reports